33.38
price up icon2.42%   0.79
 
loading
Liquidia Corp stock is traded at $33.38, with a volume of 919.80K. It is up +2.42% in the last 24 hours and up +17.91% over the past month. Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$32.59
Open:
$32.71
24h Volume:
919.80K
Relative Volume:
0.39
Market Cap:
$2.90B
Revenue:
$19.32M
Net Income/Loss:
$-141.47M
P/E Ratio:
-19.81
EPS:
-1.6851
Net Cash Flow:
$-120.48M
1W Performance:
-2.99%
1M Performance:
+17.91%
6M Performance:
+131.00%
1Y Performance:
+203.18%
1-Day Range:
Value
$32.65
$33.75
1-Week Range:
Value
$32.11
$35.54
52-Week Range:
Value
$10.37
$35.54

Liquidia Corp Stock (LQDA) Company Profile

Name
Name
Liquidia Corp
Name
Phone
919.328.4400
Name
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Name
Employee
170
Name
Twitter
@Liquidia_Inc
Name
Next Earnings Date
2025-03-19
Name
Latest SEC Filings
Name
LQDA's Discussions on Twitter

Compare LQDA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LQDA
Liquidia Corp
33.38 2.84B 19.32M -141.47M -120.48M -1.6851
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-20-25 Initiated Wells Fargo Overweight
Aug-15-25 Resumed Jefferies Buy
May-19-25 Downgrade Oppenheimer Perform → Underperform
Dec-20-24 Initiated Wells Fargo Overweight
Oct-16-24 Initiated Scotiabank Sector Outperform
Aug-19-24 Upgrade Raymond James Outperform → Strong Buy
Aug-16-24 Initiated Raymond James Outperform
Jun-25-24 Initiated Oppenheimer Perform
Jan-05-24 Reiterated Needham Buy
Sep-19-22 Resumed Wedbush Underperform
Sep-01-22 Downgrade Wedbush Neutral → Underperform
Jul-22-22 Initiated Ladenburg Thalmann Buy
May-31-22 Initiated BTIG Research Buy
May-26-22 Initiated BofA Securities Buy
Dec-04-20 Initiated H.C. Wainwright Buy
Nov-20-20 Downgrade Wedbush Outperform → Neutral
Nov-08-18 Resumed Jefferies Buy
Sep-05-18 Initiated Wedbush Outperform
Aug-20-18 Initiated Jefferies Buy
Aug-20-18 Initiated Needham Buy
View All

Liquidia Corp Stock (LQDA) Latest News

pulisher
Dec 13, 2025

AWH Capital L.P. Takes $866,000 Position in Liquidia Corporation $LQDA - MarketBeat

Dec 13, 2025
pulisher
Dec 11, 2025

Arquitos Capital Management’s Updates on Liquidia Corporation (LQDA) - Yahoo Finance

Dec 11, 2025
pulisher
Dec 11, 2025

HighVista Strategies LLC Sells 82,869 Shares of Liquidia Corporation $LQDA - MarketBeat

Dec 11, 2025
pulisher
Dec 10, 2025

Velan Capital Investment Management LP Cuts Stock Position in Liquidia Corporation $LQDA - MarketBeat

Dec 10, 2025
pulisher
Dec 09, 2025

Liquidia (NASDAQ:LQDA) Hits New 12-Month HighShould You Buy? - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Pale Fire Capital SE Invests $1.07 Million in Liquidia Corporation $LQDA - MarketBeat

Dec 08, 2025
pulisher
Dec 05, 2025

Assessing Liquidia (LQDA) Valuation After Strong Q3 Earnings Beat and Surging Yutrepia Sales - simplywall.st

Dec 05, 2025
pulisher
Dec 05, 2025

Stonepine Capital Management LLC Invests $623,000 in Liquidia Corporation $LQDA - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

How Liquidia Corporation stock compares to industry benchmarksJuly 2025 Patterns & Fast Entry and Exit Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Liquidia Corporation (LT4) stock is trending on social mediaWeekly Investment Summary & Growth Oriented Trade Recommendations - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Liquidia Corporation (LT4) stock outperform small cap peers2025 Retail Activity & Low Drawdown Trading Techniques - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

What analysts say about Liquidia Corporation LT4 stockMoving Average Strategies & Beat the Market With Predictive Algorithms - earlytimes.in

Dec 03, 2025
pulisher
Dec 03, 2025

Michael Kaseta Sells 1,166 Shares of Liquidia (NASDAQ:LQDA) Stock - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia (NASDAQ:LQDA) Insider Jason Adair Sells 693 Shares - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia (NASDAQ:LQDA) General Counsel Sells $34,507.68 in Stock - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia (NASDAQ:LQDA) Insider Scott Moomaw Sells 831 Shares - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia Technologies stock hits 52-week high at 32.96 USD - Investing.com

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia Technologies stock hits 52-week high at 32.96 USD By Investing.com - Investing.com Canada

Dec 03, 2025
pulisher
Dec 03, 2025

LQDA SEC FilingsLiquidia Corporation 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 03, 2025
pulisher
Dec 03, 2025

Stronger‑Than‑Expected Yutrepia Sales Might Change The Case For Investing In Liquidia (LQDA) - simplywall.st

Dec 03, 2025
pulisher
Dec 02, 2025

Liquidia corp general counsel sells $34507 in LQDA stock By Investing.com - Investing.com South Africa

Dec 02, 2025
pulisher
Dec 02, 2025

Liquidia corp general counsel sells $34507 in LQDA stock - Investing.com

Dec 02, 2025
pulisher
Dec 02, 2025

Officer Adair Acquires 870 Of Liquidia Corp [LQDA] - TradingView

Dec 02, 2025
pulisher
Dec 02, 2025

Virtus Investment Advisers LLC Has $81,000 Position in Liquidia Corporation $LQDA - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Liquidia (LQDA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

Why Liquidia Corporation (LT4) stock appears on watchlistsMarket Risk Analysis & Low Risk High Reward Trade Ideas - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Liquidia Corporation (NASDAQ:LQDA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 02, 2025
pulisher
Dec 01, 2025

Geode Capital Management LLC Has $17.52 Million Stake in Liquidia Corporation $LQDA - MarketBeat

Dec 01, 2025
pulisher
Nov 30, 2025

119,179 Shares in Liquidia Corporation $LQDA Acquired by XTX Topco Ltd - MarketBeat

Nov 30, 2025
pulisher
Nov 29, 2025

Can Liquidia Corporation stock sustain free cash flow growthPortfolio Update Summary & Safe Entry Point Identification - moha.gov.vn

Nov 29, 2025
pulisher
Nov 28, 2025

Liquidia’s YUTREPIA Drives Unexpected Operating Profits In Q3 - Finimize

Nov 28, 2025
pulisher
Nov 27, 2025

What technical charts say about Liquidia Corporation stockSwing Trade & Weekly Chart Analysis and Guides - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 25, 2025

Liquidia Technologies stock hits 52-week high at $30.89 By Investing.com - Investing.com South Africa

Nov 25, 2025
pulisher
Nov 25, 2025

Liquidia Technologies stock hits 52-week high at $30.89 - Investing.com

Nov 25, 2025
pulisher
Nov 24, 2025

When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable? - 富途牛牛

Nov 24, 2025
pulisher
Nov 23, 2025

CenterBook Partners LP Raises Stock Position in Liquidia Corporation $LQDA - MarketBeat

Nov 23, 2025
pulisher
Nov 23, 2025

Liquidia (LQDA) Climbs 10.7%, Nears 52-Week High on Strong Demand for Heart Treatment - MSN

Nov 23, 2025
pulisher
Nov 22, 2025

A Fresh Look at Liquidia (LQDA) Valuation Following Recent Share Price Surge - Yahoo Finance

Nov 22, 2025
pulisher
Nov 22, 2025

Is It Too Late to Consider Liquidia After 140.6% Surge and Regulatory Milestone? - Yahoo Finance

Nov 22, 2025
pulisher
Nov 20, 2025

Liquidia Corp's Chief Business Officer Sells Shares - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

[Form 4] Liquidia Corp Insider Trading Activity - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Meridian Wealth Management LLC Takes $168,000 Position in Liquidia Corporation $LQDA - MarketBeat

Nov 20, 2025
pulisher
Nov 20, 2025

What sentiment indicators say about Liquidia Corporation stockJuly 2025 Trends & Safe Entry Zone Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why Liquidia Corporation (LT4) stock fits value portfolios2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Liquidia Corporation (LT4) stock reacts to new regulationsWall Street Watch & Technical Entry and Exit Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Healthcare’s Momentum Gathers Steam. 3 Stocks With Bullish Charts. - Barron's

Nov 19, 2025
pulisher
Nov 19, 2025

Liquidia (NASDAQ:LQDA) Hits New 52-Week HighHere's Why - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

Liquidia Corporation $LQDA Stock Position Cut by Patient Square Capital LP - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

Why Liquidia Corporation stock is a value investor pickJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 05:01:37 - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Can Liquidia Corporation (LT4) stock test all time highsJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - newser.com

Nov 18, 2025

Liquidia Corp Stock (LQDA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Liquidia Corp Stock (LQDA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Krepp Sarah
Chief Human Resource Officer
Dec 01 '25
Sale
32.19
221
7,114
141,218
Kaseta Michael
CFO and COO
Dec 01 '25
Sale
32.19
1,166
37,534
353,823
Boyle Dana
Chief Accounting Officer
Dec 01 '25
Sale
32.19
303
9,754
155,031
Adair Jason
Chief Business Officer
Dec 01 '25
Sale
32.19
693
22,308
175,868
Moomaw Scott
Chief Commercial Officer
Dec 01 '25
Sale
32.19
831
26,750
154,506
Adair Jason
Chief Business Officer
Nov 18 '25
Option Exercise
5.89
35,656
210,014
210,654
Adair Jason
Chief Business Officer
Nov 18 '25
Sale
30.03
35,656
1,070,710
174,998
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Cap:     |  Volume (24h):